Literature DB >> 20398109

Keratoprostheses in clinical practice - a review.

Ahmed Gomaa1, Oliver Comyn, Christopher Liu.   

Abstract

The search for a substitute for the natural cornea dates back more than 200 years. Although several devices have been developed and trialled, very few have had successful long-term results and continue in regular clinical use. Keratoprosthesis (KPro) surgery is complex and should be performed in centres with an experienced multidisciplinary team. Currently available KPro devices range from the totally synthetic, such as the Boston KPro, to the totally biological tissue-engineered artificial cornea. The osteo-odonto keratoprothesis combines a synthetic optic with a biological haptic. All keratoprostheses have significant limitations, although visual improvement is possible with each of the devices in clinical use today. This review discusses these devices with emphasis on their indications, surgical techniques and results, before briefly exploring emerging devices and innovative approaches for the future.

Mesh:

Year:  2010        PMID: 20398109     DOI: 10.1111/j.1442-9071.2010.02231.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  24 in total

1.  Study on the optical property and biocompatibility of a tissue engineering cornea.

Authors:  Xu Zhang; Yukiko Nakahara; Dwight Xuan; Di Wu; Fang-Kun Zhao; Xiao-Yan Li; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

2.  Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model.

Authors:  D Karamichos; A E K Hutcheon; J D Zieske
Journal:  J Tissue Eng Regen Med       Date:  2011-05-23       Impact factor: 3.963

3.  Promotion of minTBP-1-PRGDN on the attachment, proliferation and collagen I synthesis of human keratocyte on titanium.

Authors:  Xin-Yu Li; Cai-Ni Ji; Ling-Juan Xu; Wei-Kun Hu; Bin Zhou; Gui-Gang Li
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 4.  High-risk corneal allografts: A therapeutic challenge.

Authors:  Tian Yu; Vijayalakshmi Rajendran; May Griffith; John V Forrester; Lucia Kuffová
Journal:  World J Transplant       Date:  2016-03-24

5.  Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases.

Authors:  Stanislav Iakymenko
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

6.  Osteo-odonto keratoprosthesis in Stevens-Johnson syndrome: a case report.

Authors:  Reddy Sc; Tajunisah I; Tan D T
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

7.  Implantation of Iakymenko keratoprosthesis in patients with severe ocular injury.

Authors:  Hong-Wei Pan; Stanislav Iakymenko; Jin-Tang Xu; Guang-Hui Hou; Bing-Ji Sun; A-Ning Zheng
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

8.  Retention of the Boston keratoprosthesis type 1: multicenter study results.

Authors:  Joseph B Ciolino; Michael W Belin; Amit Todani; Khalid Al-Arfaj; Christopher J Rudnisky
Journal:  Ophthalmology       Date:  2013-03-15       Impact factor: 12.079

Review 9.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

10.  Hydrogel membranes based on genipin-cross-linked chitosan blends for corneal epithelium tissue engineering.

Authors:  Maria Grolik; Krzysztof Szczubiałka; Bogumił Wowra; Dariusz Dobrowolski; Bogusława Orzechowska-Wylęgała; Edward Wylęgała; Maria Nowakowska
Journal:  J Mater Sci Mater Med       Date:  2012-05-09       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.